These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16765598)

  • 1. Highly antiproliferative, low-calcemic, side-chain amide and hydroxamate analogs of the hormone 1alpha,25-dihydroxyvitamin D3.
    Sinishtaj S; Jeon HB; Dolan P; Kensler TW; Posner GH
    Bioorg Med Chem; 2006 Sep; 14(18):6341-8. PubMed ID: 16765598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
    Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
    J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly antiproliferative, low-calcemic, side-chain ketone analogs of the hormone 1alpha,25-dihydroxyvitamin D3.
    Posner GH; Kim HJ; Kahraman M; Jeon HB; Suh BC; Li H; Dolan P; Kensler TW
    Bioorg Med Chem; 2005 Oct; 13(19):5569-80. PubMed ID: 16039132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-ring hydroxymethyl 19-nor analogs of the natural hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
    Hatcher MA; Peleg S; Dolan P; Kensler TW; Sarjeant A; Posner GH
    Bioorg Med Chem; 2005 Jun; 13(12):3964-76. PubMed ID: 15878279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
    Petersen KS; Dolan PM; Kensler TW; Peleg S; Posner GH
    J Med Chem; 2007 Nov; 50(23):5824-32. PubMed ID: 17924616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
    Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry.
    Posner GH; Jeon HB; Sarjeant A; Riccio ES; Doppalapudi RS; Kapetanovic IM; Saha U; Dolan P; Kensler TW
    Steroids; 2004; 69(11-12):757-62. PubMed ID: 15579327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.
    Carballa DM; Seoane S; Zacconi F; Pérez X; Rumbo A; Alvarez-Díaz S; Larriba MJ; Pérez-Fernández R; Muñoz A; Maestro M; Mouriño A; Torneiro M
    J Med Chem; 2012 Oct; 55(20):8642-56. PubMed ID: 22989379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative and calcemic actions of trans-decalin CD-ring analogs of 1,25-dihydroxyvitamin D3.
    Eelen G; Verlinden L; Laureys J; Marcelis S; De Clercq P; Mathieu C; Bouillon R; Verstuyf A
    Anticancer Res; 2009 Sep; 29(9):3579-84. PubMed ID: 19667151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
    Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
    Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
    Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel vitamin D3 antipsoriatic antedrugs: 16-En-22-oxa-1alpha,25-(OH)2D3 analogs.
    Shimizu K; Kawase A; Haneishi T; Kato Y; Kobayashi T; Sekiguchi N; Yamamoto T; Ishigai M; Tokuda K; Matsushita T; Shimaoka S; Morikawa K
    Bioorg Med Chem; 2006 Mar; 14(6):1838-50. PubMed ID: 16307885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
    Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1alpha, 25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation.
    Posner GH; Lee JK; Wang Q; Peleg S; Burke M; Brem H; Dolan P; Kensler TW
    J Med Chem; 1998 Jul; 41(16):3008-14. PubMed ID: 9685240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations.
    Vanhooke JL; Tadi BP; Benning MM; Plum LA; DeLuca HF
    Arch Biochem Biophys; 2007 Apr; 460(2):161-5. PubMed ID: 17227670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC; Mouriño A; Rochel N; Moras D
    J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
    Posner GH; Wang Q; Han G; Lee JK; Crawford K; Zand S; Brem H; Peleg S; Dolan P; Kensler TW
    J Med Chem; 1999 Sep; 42(18):3425-35. PubMed ID: 10479276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
    Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of the 2-alkyl and 2-alkylidene-19-nor-(20S)-modified analogs of 1alpha,25-dihydroxyvitamin D3.
    DeLuca HF
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):67-73. PubMed ID: 15225749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.